• 1. An integrated digital microfluidic chip for multiplexed proteomic sample preparation and analysis by MALDI-MS?
  Hyejin Moon,Aaron R. Wheeler,Robin L. Garrell,Chang-Jin “CJ” Kim Lab Chip, 2006,6, 1213-1219
• 2. An approach to biodegradable star polymeric architectures using disulfide coupling?
  Jingquan Liu,Huiyun Liu,Zhongfan Jia,Volga Bulmus,Thomas P. Davis Chem. Commun., 2008, 6582-6584
• 3. An atmosphere and light tuned highly diastereoselective synthesis of cyclobuta/penta[b]indoles from aniline-tethered alkylidenecyclopropanes with alkynes?
  Bo Cao,Yin Wei Chem. Commun., 2018,54, 2870-2873
• 4. An Aptamer Bio-barCode (ABC) assay using SPR, RNase H, and probes with RNA and gold-nanorods for anti-cancer drug screening
  Chengbin Yang,Hing Lun Tsang,Pui Man Lau,Ken-Tye Yong,Ho Pui Ho,Siu Kai Kong Analyst, 2017,142, 3579-3587
• 5. An insight into the role of side chains in the microstructure and carrier mobility of high-performance conjugated polymers?
  Jianyao Huang,Dong Gao,Zhihui Chen,Weifeng Zhang Polym. Chem., 2021,12, 2471-2480

Introduction to 1H-Pyrazole-4-carboxylic acid, 5-chloro-1-phenyl-3-(trifluoromethyl) and Its Significance in Modern Chemical Biology

1H-Pyrazole-4-carboxylic acid, 5-chloro-1-phenyl-3-(trifluoromethyl), with the CAS number 1152972-16-1, is a structurally intriguing compound that has garnered significant attention in the field of chemical biology and pharmaceutical research. This heterocyclic compound belongs to the pyrazole family, which is renowned for its broad spectrum of biological activities and therapeutic potential. The presence of multiple functional groups, including a carboxylic acid moiety, a chloro substituent, and a trifluoromethyl group, endows this molecule with unique chemical properties that make it a valuable scaffold for drug discovery and molecular design.

The 5-chloro and trifluoromethyl substituents play crucial roles in modulating the electronic and steric properties of the molecule. The chloro group can engage in hydrogen bonding interactions and influence the reactivity of adjacent functional groups, while the trifluoromethyl group enhances lipophilicity and metabolic stability, which are critical factors in drug development. These features make 1H-Pyrazole-4-carboxylic acid, 5-chloro-1-phenyl-3-(trifluoromethyl) an attractive candidate for further exploration in medicinal chemistry.

In recent years, there has been a surge in research focused on developing novel heterocyclic compounds with therapeutic applications. Pyrazole derivatives have been extensively studied due to their ability to interact with biological targets such as enzymes and receptors. The structural versatility of pyrazoles allows for the design of molecules with tailored pharmacological properties. For instance, studies have demonstrated that pyrazole-based compounds can exhibit anti-inflammatory, antimicrobial, and anticancer activities.

The carboxylic acid group in 1H-Pyrazole-4-carboxylic acid, 5-chloro-1-phenyl-3-(trifluoromethyl) provides a site for further functionalization, enabling the synthesis of more complex derivatives. This functionality is particularly useful in medicinal chemistry for the preparation of esters, amides, and other bioactive molecules. Additionally, the phenyl ring introduces hydrophobic interactions and can be modified to enhance binding affinity to biological targets.

Recent advancements in computational chemistry have facilitated the rapid design and optimization of heterocyclic compounds like 1H-Pyrazole-4-carboxylic acid, 5-chloro-1-phenyl-3-(trifluoromethyl). Molecular docking studies have shown that this compound can interact with various protein targets, suggesting its potential as a lead compound for drug development. For example, preliminary studies indicate that it may inhibit enzymes involved in cancer cell proliferation and inflammation.

The synthesis of 1H-Pyrazole-4-carboxylic acid, 5-chloro-1-phenyl-3-(trifluoromethyl) involves multi-step organic reactions that highlight the synthetic versatility of pyrazole derivatives. The introduction of the chloro and trifluoromethyl groups requires careful control of reaction conditions to ensure high yield and purity. Advanced synthetic techniques such as cross-coupling reactions and palladium catalysis have been employed to construct the desired framework efficiently.

In conclusion, 1H-Pyrazole-4-carboxylic acid, 5-chloro-1-phenyl-3-(trifluoromethyl) represents a promising compound in the realm of chemical biology and pharmaceutical research. Its unique structural features and potential biological activities make it a valuable scaffold for further exploration. As research continues to uncover new therapeutic targets and develop innovative synthetic methodologies, compounds like this are poised to play a significant role in the discovery of next-generation drugs.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)